Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious infections, announced today its financial results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
SAN DIEGO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious infections, announced today its financial results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
